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INTRODUCTION
Total hip replacement (THR) provides a very effective
symptomatic and functional treatment in a wide variety
of conditions including osteoarthritis, inflammatory
arthritis, infections etc. Osteoarthritis (OA) is the most
common indication for THR. Treatment modalities for hip
pain in OA include conservative measures (analgesia,
exercise, education, weight reduction), with surgical
intervention i.e. THR being the most effective treatment
for end stage disease.1,2 Most common indications for
THR are to alleviate pain and improve functional status,3
hence every effort is made to yield best possible
outcomes. Despite the efficacy of THR, complications
can occur resulting in poor functional outcomes for such
patients.
Common major complications include mortality,
infection, dislocation, revision, and pulmonary embolism.
The rates of these complications vary across different
registry and health care systems. Several factors have
been implicated in increasing the morbidity after THR.4-11
Identifying risk factors that predict postoperative
complications and, more specifically, being able to
predict those patients at higher risk of complications
before surgery, is an important step in searching for
strategies that might reduce complication rates.
Various modifications in the component designs and
metallurgy have been tried in the developed countries in
order to get superior results, avoid complication and
improve longevity of implant. However, the issues are
different from a developing country perspective,
where the debate moves around the prevention of
complications with the use of standardized implant
design and composition. There are several studies
focusing on the same topic from developed nations;
however, data is lacking from low income countries. 
The objective of this study was to determine the factors
associated with complications in adult patients who
underwent unilateral THR at the Aga Khan University
Hospital, Karachi.
METHODOLOGY
Adult patients who underwent unilateral total hip replace-
ment at the Aga Khan University Hospital, Karachi,
between 2000 and 2010 were included. Patients were
identified from hospital information management
system by ICD code 81.51. Patients requiring revision
arthroplasty, bilateral arthroplasty; those transferred or
initially treated at other institutions and those with
missing data were excluded. After reviewing the files,
the patients were divided into groups of those with
complications and those without complications.
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Medical records of all the patients were reviewed by
orthopaedic resident and pertinent details recorded
were baseline demographics, medical co-morbids,
indication for surgery, hip deformity, pre-operative
anticoagulation and surgical factors (including surgical
approach, type of prosthesis, use of cement, operative
times). Complications were divided into major (requiring
intervention in operating room) and minor complications
(managed without intervention). As per institutional
guidelines, this study fulfilled the criteria for exemption of
ethical review committee approval as it was a
retrospective review of the available data.
Data was analyzed in Statistical Package for Social
Sciences (SPSS) version 17. Continuous variables were
analyzed as means ± standard deviation if normal
distribution was found on histograms with distribution
curve and student t-test was applied to compare cases
and controls. Categorical variables were analyzed as
proportion and percentages and chi-square test was
used to compare cases with controls. All those risk
factors which turned out to significantly influence the
morbidity at 15% level of significance on univariate
analysis were then analyzed by multivariate logistic
regression. Association of factors with complications is
presented as adjusted odd's ratio (AOR) with 95%
confidence interval (CI). The significance level was set
at p < 0.05 for multivariate analysis.
RESULTS
During the study period, 215 patients underwent total hip
replacement; 16 patients were excluded from the study
due to missing data. Data were analyzed for 199
patients; 39 cases with complication and 160 cases
without complications. The mean age of patients was
49.6 + 16.5 years. Male to female ratio was 1:1. Most
common indication for THR was osteoarthritis (31.2%)
and avascular necrosis (30.2%), followed by ankylosing
spondylitis (10%) and tuberculosis (6.5%).
Baseline comparison of cases and controls is
summarized in Table I. Duration of surgery was longer in
cases as compared to controls (232 ± 79 minutes vs.
197 ± 67 minutes, p = 0.012). Cases had higher frequency
of ASA III-IV, peri-operative transfusion, hip deformity,
and postoperative bisphosphonate use.
Postoperative complications occurred in 39 patients
(19.6%); dislocation being most common in 13 patients
(6.5%), followed by wound infection in 4 (2%), all of
these patients required intervention. Other minor compli-
cations which were managed conservatively included
wound infection (2.5%), urinary tract infection (2.5%),
dislocation (1%), pleural effusion and pneumonia (2%),
deep venous thrombosis (0.5%) and myocardial
infarction (0.5%).
On univariate analysis, ASA III and IV, peri-operative
blood transfusion, pre-operative hip deformity and
post-operative bisphosphonate use were significantly
associated with complications. On multi-variate analysis,
adjusted odd's ratio with 95% confidence interval for
perioperative transfusion 3, 95% CI: 1.17-7.4 and hip
deformity (n = 3.2, 1.4-7.4) were found statistically
significant (Table II).
DISCUSSION
In this study, major postoperative complications
occurred in 19.6% patients; dislocation followed by
wound infection were the most common complications.
On multivariate analysis, patients with pre-operative hip
deformity and perioperative blood transfusion had three
times greater odds of having complications as compared
to controls.
Dislocation and wound infection are the two major
complications of THR,4,5 as observed in other hip
surgeries like hemiarthroplasty.12 The incidence of
dislocation after THR ranges between 0.5% to nearly
10%.13,14 There is paucity of data pertaining to the risk
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Table I: Baseline comparison of cases and controls.
Variables All Cases Controls p-value
(n=199) (n=39) (n=160)
Age 49.6 ± 16.5 52 ± 16.8 49 ± 16.4 0.31
ASA
I-II 146 (73.4%) 24 (61.5%) 122 (76%)
III-IV 53 (26.6%) 15 (38.5%) 38 (28%) 0.0452
BMI 26.4 ± 6.9 27.4 ± 6.8 26.1 ± 6.9 0.291
< 25 93 (46.7%) 17 (43%) 76 (47%)
25-29.9 68 (34.2%) 10 (25.6%) 58 (36.3%)
≥ 30 38 (19.1%) 12 (30%) 26 (16.2%) 0.0672
Hip deformity 68 (34.2%) 19 (48.7%) 49 (30.6%) 0.0182
Length of surgery 204 ± 70 232 ± 79 197 ± 67 0.0121
Estimated blood loss 622 ± 321 680 ± 401 608 ± 298 0.211
Blood transfusion 120 (60.3%) 32 (82 %) 88 (55%) 0.0012
Anti-coagulants 155 (77.9%) 30 (76.9%) 125 (78.1%) 0.512
Prolonged antibiotics 43 (21.6%) 13 (33.3%) 30 (18.8%) 0.0622
Postoperative 
bisphosphonates 04 (2%) 03 (7.7%) 01 (0.6%) 0.0242
Length of hospital stay 11.8 ± 7.8 15 ± 13.5 11 ± 5.5 0.0871
1Student's t-test,   2Chi square test.
Table II: Univariate and multivariate analysis of predictive factors.
Variables Univariate OR Multivariable analysis
AOR 95%CI p-value
ASA
I-II 1 1 -
III-IV 0.48 0.43 0.14-1.01 0.054
Blood transfusion
No 1 1 -
Yes 3.6 3 1.17-7.7 0.022
Hip deformity
No 1 1 1




Yes 13.2 11.5 0.95-141 0.055
factors of complications of THR from developing
countries. Comparison with data from developed world
may be unjustified because of difference in case mix,
surgical practices, quality of care, financial and social
conditions. However, studies from the developed
countries demonstrate that various factors are
implicated in affecting rates of dislocation including: (a)
patient factors, such as gender, weak hip musculature,
excessive alcohol intake, smoking,7 body mass index,7
primary disease/indication8 and age; (b) surgical factors,
such as surgical approach, capsular excision or repair,
positioning of implant, and previous hip surgery;8,10 and
(c) implant factors, such as femoral neck length, offset
and head diameter.15
Pre-operative deformity has been shown to have
positive association with postoperative morbidities such
as leg length discrepancy and abductors imbalances,
which may lead to poor satisfaction of patients and
recurrent dislocations, respectively. In this series it was
observed that patient with pre-operative flexion
contracture of > 30 degree have high rates of compli-
cations including dislocation and wound infections.
Most previous studies on orthopaedic patients have
reported an increased risk of postoperative infections,
short-term mortality, length of hospital stay and intensive
care unit stay in patients receiving blood transfusions.16
Marik and Corwin published a systematic review based
on 45 cohort studies, suggesting that transfusions are
associated with increased morbidity and mortality risk in
high risk hospitalized patients.17 The present results are
also consistent with this observation. Higher rates of
transfusion may reflect the overall difficulty of procedure
leading to prolonged surgery and greater blood loss and
subsequent need of transfusion. Moreover, the process
of transfusion itself limits mobility of patient and prolongs
the length of bed rest with subsequent problems of
recumbency such as heel sore and atelectasis. The
duration of surgery and the length of bed rest/
immobilization are influenced by other factors as well,
which were, however, not analyzed in this study.
Therefore, every effort should be made to minimize the
blood loss to reduce the risk of complications.
There is an increased risk of revision due to deep
infection in postoperative users of bisphosphonates.
Bacterial pathogens, causing periprosthetic joint infec-
tion, can stimulate osteoclastogenesis and potentiate
bone resorption in order to clear the infection. However,
osteoclastogenesis is inhibited by bisphosphonates and,
therefore, results in an inappropriate response to
periprosthetic joint infection and thus exacerbation of the
course of infection. In a study by Thillman et al., 10-year
cumulated implant revision rate in the underlying cohort
of 16,145 primary THA procedures among osteoporotic
patients was 8.3% (95% confidence interval (CI):
7.3 - 9.3).18 The use of bisphosphonates was asso-
ciated with an adjusted relative risk of revision due to
deep infections of 2.59 (95% CI; 1.30 - 6.53).18 In this
study, we had 3 patients with postoperative use of
bisphosphonates; two developed wound infection and
third had dislocation after stumbling in washroom, which
was reduced in ward under cover of intravenous
pethidine and diazepam.
This study provides an experience of THR from a tertiary
care hospital of developing country and the complication
rate is higher as compared to developed countries. This
might be attributed to different surgical practices and
postoperative care. Where the world is moving from
conventional to fast track surgeries in order to reduce
the complications,1,2 there was a quite prolonged
hospital stay i.e. 11.8 ± 7.8 days in this study. Apart from
that, this is a retrospective study; there might be
reviewer's bias and missing data bias confronted during
chart reviewing. One of the major determinants of
surgical outcomes is the surgeon itself; and this study
reports experiences of more than one surgeons. There
is also limited sample size of this study as evident from
the fact that ASA III-IV and peri-operative bisphos-
phonates use were statistically significant on univariate
analysis, but became insignificant on multivariable
analysis. This might be due to the limited sample size.
The evidence may further be strengthened by
conducting a prospective multicentre study with a larger
sample size.
CONCLUSION
The results from this study indicate that pre-operative
hip deformity and perioperative blood transfusion
significantly influence the rates of complications after
THR. Based on this observation, one might be able to
control or at least identify individuals who would require
greater attention in term of postoperative rehabilitaiton
and critical care requirements.
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